Morgan Stanley Reiterates Equal-Weight Rating on Waters Corporation (WAT)

Market Context

Waters Corporation operates in the Healthcare sector. The stock currently trades at $377.13 with a market capitalization of $23.4B. The stock has declined 0.8% over the past 52 weeks.

Analyst coverage from Morgan Stanley provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Waters Corporation.

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for Waters Corporation

Among the 10 most recent ratings: 6 Buy, 4 Hold, 0 Sell.

Date	Firm	Rating	Price Target
Jul 09, 2026	RBC Capital	Outperform	N/A
Jul 09, 2026	Morgan Stanley	Equal-Weight	N/A
Jul 08, 2026	Guggenheim	Buy	N/A
Jul 06, 2026	Evercore ISI Group	Outperform	N/A
Jun 26, 2026	Bernstein	Outperform	N/A

Related Tools: Analyst Ratings Dashboard | View WAT Stock Page